Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocort in active ulcerative colitis
2010-020448-37Phase 2Terminated
- Sponsor
- Enceladus Pharmaceuticals
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of hydrocortisone in autoimmune colitis (2 arms), sponsored by Enceladus Pharmaceuticals. Started Sep 2010; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2010-020448-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020448-37.